Literature DB >> 26823754

HRP-3 protects the hepatoma cells from glucose deprivation-induced apoptosis.

Hao Cai1, Deke Jiang2, Fang Qi3, Jianfeng Xu4, Long Yu1, Qianyi Xiao4.   

Abstract

UNLABELLED: Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide. It is important for HCC cells to resist to apoptosis caused by adverse energy pressure in microenvironment during the HCC tumorigenesis. HRP-3, a member of hepatoma-derived growth factor (HDGF)-related proteins (HRP) family, was shown to be highly up-regulated in HCC tissues and play an important role in HCC pathogenesis based on our previous research. The aim of the study was to investigate the HRP-3's role in HCC cells endurance against energy pressure.
METHOD: The HRP-3 expression level in primary rat hepatocytes and human HCC cell lines were examined when changing the extracellular glucose concentration. To assess biological function of HRP-3 during glucose deprivation, HRP-3 stable knockdown and control clones of SMMC-7721 and SK-hep1 were constructed for further analysis including cellular morphology observation, apoptotic sub G1 peak analysis and the mTOR-mediated phosphorylation of S6K1 detection in the absence of glucose.
RESULTS: Expression level of HRP-3 protein was highly up-regulated both in primary rat hepatocytes and HCC cells as prolonging the stimulation of glucose deprivation. Both morphology and sub-G1 phase analyses indicated that stable knockdown of HRP-3 sensitized HCC cells to glucose deprivation-induced cell apoptosis. Furthermore, silence of HRP-3 prevented the de-phosphorylation of S6K1 induced by glucose deprivation, which was an essential molecular event for HCC cell survival in energy pressure.
CONCLUSIONS: We propose that glucose deprivation-induced HRP-3 up-regulation potentially plays a major role in protecting HCC cells against apoptosis caused by energy pressure.

Entities:  

Keywords:  HRP-3; Hepatocellular carcinoma; apoptosis; glucose deprivation

Mesh:

Substances:

Year:  2015        PMID: 26823754      PMCID: PMC4713540     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  35 in total

1.  beta-catenin signaling pathway and the tolerance of breast cancer cells to hypoxic conditions.

Authors:  A M Scherbakov; L B Stefanova; I A Yakushina; M A Krasilnikov
Journal:  Klin Lab Diagn       Date:  2013-10

Review 2.  Cancer immunotherapy and breaking immune tolerance: new approaches to an old challenge.

Authors:  Amani Makkouk; George J Weiner
Journal:  Cancer Res       Date:  2014-12-18       Impact factor: 12.701

3.  Global cancer statistics, 2012.

Authors:  Lindsey A Torre; Freddie Bray; Rebecca L Siegel; Jacques Ferlay; Joannie Lortet-Tieulent; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2015-02-04       Impact factor: 508.702

4.  The mechanistic target of rapamycin (mTOR) pathway and S6 Kinase mediate diazoxide preconditioning in primary rat cortical neurons.

Authors:  Somhrita Dutta; Ibolya Rutkai; Prasad V G Katakam; David W Busija
Journal:  J Neurochem       Date:  2015-07-01       Impact factor: 5.372

5.  A treadmill exercise reactivates the signaling of the mammalian target of rapamycin (mTor) in the skeletal muscles of starved mice.

Authors:  Dong-Mei Zheng; Zehua Bian; Norihiko Furuya; Juan Alejandro Oliva Trejo; Mitsue Takeda-Ezaki; Katsuyuki Takahashi; Yuka Hiraoka; Reiko Mineki; Hikari Taka; Shin-Ichi Ikeda; Masaaki Komatsu; Tsutomu Fujimura; Takashi Ueno; Junji Ezaki
Journal:  Biochem Biophys Res Commun       Date:  2014-12-06       Impact factor: 3.575

6.  Effects of Lithium Niobate Polarization on Cell Adhesion and Morphology.

Authors:  Valentina Marchesano; Oriella Gennari; Laura Mecozzi; Simonetta Grilli; Pietro Ferraro
Journal:  ACS Appl Mater Interfaces       Date:  2015-08-06       Impact factor: 9.229

Review 7.  Targeting the phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway: an emerging treatment strategy for squamous cell lung carcinoma.

Authors:  Joseph Thaddeus Beck; Amen Ismail; Christina Tolomeo
Journal:  Cancer Treat Rev       Date:  2014-07-03       Impact factor: 12.111

8.  Skeletal muscle hypertrophy adaptations predominate in the early stages of resistance exercise training, matching deuterium oxide-derived measures of muscle protein synthesis and mechanistic target of rapamycin complex 1 signaling.

Authors:  Matthew S Brook; Daniel J Wilkinson; William K Mitchell; Jonathan N Lund; Nathaniel J Szewczyk; Paul L Greenhaff; Ken Smith; Philip J Atherton
Journal:  FASEB J       Date:  2015-07-13       Impact factor: 5.191

9.  CRISPR/Cas9n-Mediated Deletion of the Snail 1Gene (SNAI1) Reveals Its Role in Regulating Cell Morphology, Cell-Cell Interactions, and Gene Expression in Ovarian Cancer (RMG-1) Cells.

Authors:  Misako Haraguchi; Masahiro Sato; Masayuki Ozawa
Journal:  PLoS One       Date:  2015-07-10       Impact factor: 3.240

10.  Chronic Replication Problems Impact Cell Morphology and Adhesion of DNA Ligase I Defective Cells.

Authors:  Paolo Cremaschi; Matteo Oliverio; Valentina Leva; Silvia Bione; Roberta Carriero; Giulia Mazzucco; Andrea Palamidessi; Giorgio Scita; Giuseppe Biamonti; Alessandra Montecucco
Journal:  PLoS One       Date:  2015-07-07       Impact factor: 3.240

View more
  3 in total

1.  Cell death in a co-culture of hepatocellular carcinoma cells and human umbilical vascular endothelial cells in a medium lacking glucose and arginine.

Authors:  Minoru Tomizawa; Fuminobu Shinozaki; Yasufumi Motoyoshi; Takao Sugiyama; Shigenori Yamamoto; Naoki Ishige
Journal:  Oncol Lett       Date:  2016-11-30       Impact factor: 2.967

2.  A Benzylideneacetophenone Derivative Induces Apoptosis of Radiation-Resistant Human Breast Cancer Cells via Oxidative Stress.

Authors:  Jeong Eon Park; Mei Jing Piao; Kyoung Ah Kang; Kristina Shilnikova; Yu Jae Hyun; Sei Kwan Oh; Yong Joo Jeong; Sungwook Chae; Jin Won Hyun
Journal:  Biomol Ther (Seoul)       Date:  2017-07-01       Impact factor: 4.634

3.  Identification of a neural development gene expression signature in colon cancer stem cells reveals a role for EGR2 in tumorigenesis.

Authors:  Joseph L Regan; Dirk Schumacher; Stephanie Staudte; Andreas Steffen; Ralf Lesche; Joern Toedling; Thibaud Jourdan; Johannes Haybaeck; Nicole Golob-Schwarzl; Dominik Mumberg; David Henderson; Balázs Győrffy; Christian R A Regenbrecht; Ulrich Keilholz; Reinhold Schäfer; Martin Lange
Journal:  iScience       Date:  2022-05-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.